Search

Kaftrio now approved for 2–5-year-olds

The UK medicines regulator, the MHRA, has today extended the licence of the CF drug – Kaftrio (ivacaftor, tezacaftor, elexacaftor) – saying it is safe and effective for eligible children over 2 years old.  

Cross-infection at events

Find out more about the Cystic Fibrosis Trust's policy on cross-infection at events.

UK Health Security Agency report reveals a post-pandemic bounce back in antibiotic resistant infections

The UK Health Security Agency has shared the results of its ESPAUR report, highlighting the increase in antimicrobial resistance.

World Diabetes Day

Today is World Diabetes Day, so it’s an opportunity to raise awareness of CF diabetes, what we know about it, and how it is managed.

Latest update on the NICE appraisal of Orkambi, Symkevi and Kaftrio

Cystic Fibrosis Trust responds to NICE committee’s draft recommendations on modulator therapies Orkambi, Symkevi and Kaftrio

Sign up for pram jam

Signup form for pram jam. Part of the Strong Beginnings programmme

Lucy and the 65 Roses EP

We sat down with Lucy, a musician and songwriter with cystic fibrosis to hear all about her life with CF, her brand-new EP ‘65 Roses’ her launch event coming up this month.

Cross-infection

Find out about cross-infection in cystic fibrosis, what it means and what steps are taken to prevent it.

UK Cystic Fibrosis Registry receives grant to improve transparency of health data

The Registry is one of 19 projects to be awarded funding by the initiative